Clinical Trial Update: A Study to Evaluate the Long-term Efficacy and Safety of AK102 in Patients With Hyperlipidemia [Phase 3]

View source ↗

Summary

This clinical trial update reports a Phase 3 study evaluating the long-term efficacy and safety of AK102 in patients with hyperlipidemia, conducted by Akeso, wh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• AK102

Snippet

Sponsor: Akeso | Conditions: Hyperlipidemia | Phase 3 | Status: COMPLETED